Taysha Gene Therapies, Inc. TSHA Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s other operating expenses?
- Taysha Gene Therapies, Inc. (TSHA) reported other operating expenses of $43.49M in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s other operating expenses changed year-over-year?
- Taysha Gene Therapies, Inc.'s other operating expenses increased by 83.3% year-over-year, from $23.72M to $43.49M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s other operating expenses?
- Over 4 years (2021 to 2025), Taysha Gene Therapies, Inc.'s other operating expenses has grown at a -8.7% compound annual growth rate (CAGR), from $173.27M to $120.27M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.